re: Ann: Share transactions with major shareh... An assessment of this deal comes down to " do you want to be on the Brevagen journey or do you want a part Brevagen part Immunaid journey"
In my view the equity market (ie us) will not place any value on Immunaid where it sits now- there is no visibility through to it plus Merv is involved which turns a lot of instos off). Sure , it might be worth a lot in 5 years but let's look at some numbers.
It recently raised cash at $1.00 so if its worth $5 in 3 years its been a ball tearer. At $5 GTG's 4.5m shares would have been worth $22.50m. Now under this deal it keeps an option on half so the downside ( at a very lofty $5 ) is $11.25m for GTG plus add in the $0.5m option fee and you get $11.75m.
Now if we assume Immunaid grows from $1 to $5 over 3 years we must assume some good times for Brevagen so its apples vs apples. But lets say GTG shares only grow 3 * to 18c. On this trade GTG has effectively made (18c -8c) * 76m shares = $ 7.6m. If I assume 5* to be consistent with Immunaid's 5 * that's 30c or (30c-8c)*76m shares = $16.7m.
So, in my mind the deal itself is fair in future expectation terms - you are splitting hairs and going around and around in circles essentially debating which of Brevagen or Immunaid will be the best performer going forward . So, whether you like the deal or not SIMPLY depends on which asset you think will perform best over the say 3 year period , Brevagen or Immunaid. If you prefer Immunaid then sell your GTG shares and give Merv a call and invest there. If you think Brevagen then hold on in GTG.
And that still leaves the non-financial benefits of this deal for GTG which the above places no value on.. and that is " Merv is down to 6.2%" and cannot now vote down sensible proposals that the Board puts to shareholders. This will attract new buyers to the shares, IMHO
- Forums
- ASX - By Stock
- GTG
- Ann: Share transactions with major shareholder
Ann: Share transactions with major shareholder , page-10
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
-0.004(5.06%) |
Mkt cap ! $9.916M |
Open | High | Low | Value | Volume |
7.6¢ | 8.1¢ | 7.3¢ | $18.25K | 233.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 232 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 8905 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 232 | 0.078 |
1 | 2607 | 0.075 |
1 | 60000 | 0.074 |
1 | 50000 | 0.073 |
4 | 79000 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 1274 | 1 |
0.088 | 6500 | 1 |
0.090 | 30000 | 3 |
0.094 | 76366 | 1 |
0.095 | 77956 | 2 |
Last trade - 15.37pm 28/06/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online